Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission

This study is currently recruiting participants.
Verified February 2014 by Spectrum Health Hospitals
Sponsor:
Collaborators:
Cancer Prevention Pharmaceuticals, Inc.
University of Arizona
University of Hawaii
University of Vermont
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
ClinicalTrials.gov Identifier:
NCT01586260
First received: April 24, 2012
Last updated: February 5, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2020
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)